南财智讯7月14日电，同仁堂科技（01666.HK）发布内幕消息公告，公司于2026年7月14日收到北京市密云区人民法院送达的法律文书，获悉持股49%的股东北京德康信瑞商贸有限责任公司已向法院提交针对公司附属公司北京同仁堂兴安保健科技有限责任公司（持股51%）的解散申请。截至2025年12月31日，同仁堂兴安保健占集团收入约13.32%、年度利润约16.72%、总资产约3.17%。公司表示已自2026年3月起逐步暂停其对外委托加工类产品的生产及销售，并正就相关事项寻求中国律师法律意见；该解散申请尚未开庭审理，最终结果及对集团的实际影响存在不确定性，公司将持续监察并适时披露进展。
（文章来源：南方财经网）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.